Gabexate
Drug profile
Also known as: gabexate mesilate, gabexate mesylate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Gabexate is a drug catalogued in DrugCentral. DrugCentral lists 14 molecular targets, including TPSAB1, TMPRSS2 and HPN.
- Molecular targets: TPSAB1, TMPRSS2, HPN and PLAU (14 listed in DrugCentral).
- Molecular formula: C16H23N3O4; molecular weight 321.38 g/mol.
Mechanism & targets
Molecular targets (14)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Tryptase alpha/beta-1 | TPSAB1 | inhibitor | IC50 8.47 |
| Transmembrane protease serine 2 | TMPRSS2 | unknown | IC50 6.89 |
| Serine protease hepsin | HPN | unknown | IC50 6.42 |
| Urokinase-type plasminogen activator | PLAU | unknown | IC50 6.37 |
| Multidrug and toxin extrusion protein 1 | SLC47A1 | unknown | IC50 6.30 |
| Prothrombin | F2 | unknown | IC50 6.16 |
| Solute carrier family 22 member 2 | SLC22A2 | unknown | IC50 6.05 |
| Plasma kallikrein | KLKB1 | unknown | IC50 5.87 |
| Plasminogen | PLG | unknown | IC50 5.81 |
| Coagulation factor XII | F12 | unknown | Ki 5.54 |
| Coagulation factor X | F10 | unknown | IC50 5.34 |
| Multidrug and toxin extrusion protein 2 | SLC47A2 | unknown | IC50 4.97 |
| Tissue-type plasminogen activator | PLAT | unknown | IC50 4.81 |
| Membrane primary amine oxidase | Aoc3 | unknown | Ki 4.57 |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Disseminated intravascular coagulation | 47.2 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Gabexate is on its molecule page.
| Molecular formula | C16H23N3O4 |
|---|---|
| Molecular weight | 321.38 g/mol |
| CAS number | 39492-01-8 |
| InChIKey | YKGYIDJEEQRWQH-UHFFFAOYSA-N |
| PubChem CID | 3447 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Gabexate work?
Its molecular targets in DrugCentral include TPSAB1 (inhibitor), TMPRSS2, HPN and PLAU.
What is the chemical formula of Gabexate?
Gabexate has the molecular formula C16H23N3O4 and a molecular weight of 321.38 g/mol.
Browse: all drugs starting with G · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3257 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL87563 — compound record and bioactivity
- PubChem CID 3447 — chemical identifiers
- DrugBank DB12831 — drug record
- FDA UNII 4V7M9137X9 — substance identity
- UniProt Q15661 (TPSAB1) — target protein
- UniProt O15393 (TMPRSS2) — target protein
- UniProt P05981 (HPN) — target protein
- UniProt P00749 (PLAU) — target protein
- UniProt Q96FL8 (SLC47A1) — target protein
- UniProt P00734 (F2) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.